Law
Thailand Reclassifies High-Fluoride Oral Medications as 'Dangerous Drugs'
The Ministry of Public Health has officially designated oral medications containing 5,000 ppm fluoride as 'dangerous drugs,' effective August 19, 2026.
According to a report by Khaosod Online Thailand, the Thai Ministry of Public Health has issued a new regulation classifying oral medications containing 5,000 ppm of fluoride as 'dangerous drugs.' This announcement, published in the Royal Gazette, follows a directive signed by Minister of Public Health Phatthana Phromphat on August 6, 2026, and officially took effect on August 19, 2026.
The regulation was enacted under the authority of the Drug Act B.E. 2510 (1967), as amended by the Drug Act (No. 3) B.E. 2522 (1979), following a recommendation from the Drug Committee during their meeting on January 26, 2026.
For residents and travelers in Thailand, this reclassification signifies stricter regulatory oversight regarding the distribution and sale of high-fluoride oral products. While this change primarily impacts pharmaceutical supply chains and professional dispensing standards, individuals who use high-concentration fluoride treatments should be aware that these products are now subject to more rigorous control measures. It remains to be confirmed how this specific classification will affect the availability of these products in pharmacies or whether it will necessitate new prescription requirements for consumers. Users are encouraged to consult with local healthcare professionals regarding any changes to the accessibility of their specific oral care products.